A detailed history of Catalyst Funds Management Pty LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 16,750 shares of LLY stock, worth $13 Million. This represents 3.26% of its overall portfolio holdings.

Number of Shares
16,750
Holding current value
$13 Million
% of portfolio
3.26%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $12.9 Million - $16.1 Million
16,750 New
16,750 $14.8 Billion
Q1 2024

Dec 04, 2024

SELL
$592.2 - $792.28 $9.42 Million - $12.6 Million
-15,900 Reduced 94.93%
850 $661 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Catalyst Funds Management Pty LTD Portfolio

Follow Catalyst Funds Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.